Stock Market Update - November 13, 2025
Today's stock market saw some significant movers. Here's a breakdown of 5 stocks that caught our attention:
1. MRSN - Mersana Therapeutics, Inc.
Price: $27.43 | Change: +209.24% ($18.56)
MRSN:NASDAQ saw an astounding 209.24% gain! This massive surge came around November 2025 following the exciting news that Mersana Therapeutics would be acquired by Day One Biopharmaceuticals.
Day One agreed to pay an upfront cash consideration of $25.00 per share, which was a substantial premium of about 180-182% over Mersana’s stock price just days before the announcement. The deal also sweetens the pot with potential contingent value rights (CVRs) that could add an extra $30.25 per share if Mersana's key cancer drug, Emi-Le, hits specific development and regulatory milestones.
This acquisition is a strategic move for Day One, aiming to bolster its oncology pipeline with Emi-Le, especially for treating adenoid cystic carcinoma, a rare cancer with high unmet medical needs. Mersana's board unanimously supported the deal, which is anticipated to finalize by the end of January 2026.
2. NVVE - Nuvve Holding Corp.
Price: $0.4758 | Change: +204.61% ($0.3196)
NVVE saw its stock price rocket by an impressive 204.61% around November 14, 2025, following a major announcement from its Japanese subsidiary, NUVVE Japan Corporation. The company secured a landmark aggregation agreement in Japan, positioning them to manage a large, existing stationary storage battery system.
Under this pioneering deal—which is Japan's first such agreement for existing stationary batteries—NUVVE Japan will control the battery's operation, integrating it into Japan's supply-demand adjustment and wholesale electricity markets. This project, set to begin in the first half of 2026, aims to both generate revenue and contribute to regional power supply stability.
What makes this particularly interesting is how this single strategic agreement overshadowed other news, like reported revenue declines and increased losses for Nuvve overall, highlighting investor focus on new market opportunities and innovative energy solutions in the battery space.
3. DHAI - DIH Holding US, Inc.
Price: $0.5895 | Change: +55.13% ($0.2095)
DHAI recently saw an astonishing 55.13% gain. However, this impressive jump comes amidst a flurry of concerning news for DIH Holding US, a company focused on robotic rehabilitation technology. Around the same time as this price rise, the company faced a significant setback: The Nasdaq Stock Market denied its request to continue listing, leading to its delisting and suspension of trading on November 7, 2025. DHAI's securities are now expected to be quoted on the Over-the-Counter (OTC) market.
Adding to these woes, DIH Holding US and its auditors have expressed substantial doubt about the company's ability to continue as a "going concern." Following the delisting, the company announced it would suspend operations, citing a lack of capital for daily needs, and plans to evaluate strategic alternatives. Earlier, financial results showed a revenue decline, with the fourth quarter experiencing a sharp 34.7% decrease. Given these severe headwinds, this recent stock uptick appears to defy fundamental logic, likely reflecting short-term market dynamics or low-volume trading on the OTC market rather than a positive shift in the company's outlook.
4. SISI - Shineco, Inc.
Price: $0.3 | Change: +50.00% ($0.1)
SISI showed a significant reported 50% gain around November 14, 2025, which might catch the eye. However, this reported jump presents a peculiar situation. Nasdaq actually announced its decision to delist Shineco, Inc.'s common stock on November 7, 2025, after trading had already been suspended since October 7, 2025. This means the stock was not actively trading on the Nasdaq exchange to experience a price rise around that specific date.
Before these delisting announcements, Shineco did experience legitimate catalysts for substantial stock movements. In August 2025, its shares surged following the establishment of a Biological Cell Digital Business Division, which aimed to integrate biological cell assets with blockchain technology, leading to gains of 34-49%. Another jump occurred later that month after a strategic partnership. In September, the company announced achieving mass production of high-purity soybean phospholipids and a separate $8.7 million tech deal.
What's particularly interesting about SISI is this clear disconnect: while the company certainly had news that caused significant stock appreciation in earlier months, any reported "gain" on Nasdaq around mid-November 2025 directly contradicts its delisted and non-trading status at that time. It serves as a strong reminder to always verify the full context of any reported stock movement.
5. DRCT - Direct Digital Holdings, Inc.
Price: $0.2854 | Change: +44.07% ($0.0873)
DRCT saw its stock price climb an impressive 44.07% after Direct Digital Holdings, Inc. announced it had regained compliance with Nasdaq's minimum stockholders' equity requirement. This significant news eased immediate concerns about the company being delisted, a risk that had been weighing heavily on investors. Meeting this $2.5 million equity threshold was a major positive signal for the market.
While the equity compliance was a big win, the company still has a deadline of January 30, 2026, to meet the minimum bid price requirement, needing its stock to close at or above $1.00 for at least 10 consecutive business days. This positive development around Nasdaq compliance was so impactful that it overshadowed earlier news from the same month, which indicated a third-quarter loss and missed revenue estimates.
This analysis was generated using AI and real-time stock data. Always do your own research before making investment decisions.